We are live on ! Find out more
SVCP

Silicon Valley Capital Partners Portfolio holdings

AUM $1.02B
1-Year Est. Return 21.85%
This Fund
S&P 500
This Quarter Est. Return
+6.49%
1 Year Est. Return
+21.85%
3 Year Est. Return
+75.47%
5 Year Est. Return
+82.14%
10 Year Est. Return
+330.18%
AUM
$727M
AUM Growth
+$56.6M
Cap. Flow
+$17.9M
Cap. Flow %
2.46%
Top 10 Hldgs %
63.99%
Holding
321
New
17
Increased
137
Reduced
27
Closed
12

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$2.09M
2
SBUX icon
Starbucks
SBUX
+$1.77M
3
MSFT icon
Microsoft
MSFT
+$1.71M
4
USB icon
US Bancorp
USB
+$1.44M
5
SPGP icon
Invesco S&P 500 GARP ETF
SPGP
+$1.38M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.36M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.21M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$1.16M
4
AAPL icon
Apple
AAPL
+$839K
5
NVDA icon
NVIDIA
NVDA
+$690K

Sector Composition

Rank Sector Weight
1 Technology 22.89%
2 Financials 7.74%
3 Communication Services 6.47%
4 Consumer Discretionary 5.14%
5 Healthcare 3.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CME icon
251
CME Group
CME
$94.8B
$8.3K ﹤0.01%
42
– –
CVE icon
252
Cenovus Energy
CVE
$52.1B
$7.87K ﹤0.01%
400
+3
+0.8% +$61
VALE icon
253
Vale
VALE
$62.6B
$7.51K ﹤0.01%
672
– –
BDX icon
254
Becton Dickinson
BDX
$48.2B
$7.38K ﹤0.01%
32
+1
+3% +$236
CB icon
255
Chubb
CB
$135B
$7.17K ﹤0.01%
28
– –
COP icon
256
ConocoPhillips
COP
$141B
$6.92K ﹤0.01%
61
+1
+2% +$121
MRNA icon
257
Moderna
MRNA
$23.6B
$6.89K ﹤0.01%
58
– –
F icon
258
Ford
F
$55.7B
$6.78K ﹤0.01%
541
+7
+1% +$87
QQQM icon
259
Invesco NASDAQ 100 ETF
QQQM
$102B
$6.72K ﹤0.01%
34
– –
ISRG icon
260
Intuitive Surgical
ISRG
$134B
$6.67K ﹤0.01%
15
– –
FDX icon
261
FedEx
FDX
$75.4B
$6.66K ﹤0.01%
22
– –
DV icon
262
DoubleVerify
DV
$2.03B
$6.54K ﹤0.01%
336
– –
XYZ
263
Block Inc
XYZ
$47.5B
$6.45K ﹤0.01%
100
– –
LBRDK icon
264
Liberty Broadband Class C
LBRDK
$5.15B
$6.3K ﹤0.01%
115
– –
AMP icon
265
Ameriprise Financial
AMP
$48.8B
$6.24K ﹤0.01%
15
– –
VTV icon
266
Vanguard Morningstar Value ETF
VTV
$191B
$6.23K ﹤0.01%
39
– –
IEMG icon
267
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
$6.21K ﹤0.01%
116
+1
+0.9% +$53
DGX icon
268
Quest Diagnostics
DGX
$26.3B
$6.2K ﹤0.01%
45
– –
INSP icon
269
Inspire Medical Systems
INSP
$1.74B
$5.62K ﹤0.01%
42
– –
VHT icon
270
Vanguard Health Care ETF
VHT
$18.6B
$5.47K ﹤0.01%
21
– –
LIT icon
271
Global X Lithium & Battery Tech ETF
LIT
$1.6B
$5.36K ﹤0.01%
138
– –
FEP icon
272
First Trust Europe AlphaDEX Fund
FEP
$534M
$4.83K ﹤0.01%
131
– –
GS icon
273
Goldman Sachs
GS
$303B
$4.83K ﹤0.01%
11
– –
ATOS icon
274
Atossa Therapeutics
ATOS
$23.5M
$4.61K ﹤0.01%
258
– –
UAL icon
275
United Airlines
UAL
$42.1B
$4.38K ﹤0.01%
90
– –
9 10
11
12 13

Similar funds

EFM
EQT Fund Management Luxembourg $1.02B AUM
CC
Crosslink Capital Menlo Park, California $1.02B AUM 9.21% 1-Year Est. Return
MSA
Mason Street Advisors Milwaukee, Wisconsin $1.02B AUM 8.35% 1-Year Est. Return
IAS
IMA Advisory Services Denver, Colorado $1.02B AUM 18.66% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.01B AUM 19.71% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Silicon Valley Capital Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Silicon Valley Capital Partners held 321 positions worth $727M, up 8.5% from $670M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Silicon Valley Capital Partners's Q2 2024 filing shows 17 new, 137 increased, 27 reduced and 12 closed positions. Its largest new stake was Revance Therapeutics, Inc.: 135,788 shares worth $349K. The largest sale was Alphabet (Google) Class A, an estimated $1.36M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Communication Services.

  • Silicon Valley Capital Partners's largest Q2 2024 buy was Revance Therapeutics, Inc.: 135,788 shares worth $349K.
  • Silicon Valley Capital Partners added most to Salesforce in Q2 2024, an estimated $2.09M increase.
  • Silicon Valley Capital Partners's biggest Q2 2024 reduction was Alphabet (Google) Class A, cutting an estimated $1.36M.
  • Silicon Valley Capital Partners fully exited Baidu in Q2 2024, selling an estimated $52.6K.
  • Silicon Valley Capital Partners's ten largest holdings make up 64% of its $727M portfolio in Q2 2024.
  • Silicon Valley Capital Partners opened 17 new positions and closed 12 in Q2 2024.
  • Silicon Valley Capital Partners's portfolio value rose 8.5% quarter-over-quarter to $727M.

Based on Silicon Valley Capital Partners's 13F filing for Q2 2024, filed 30 Oct 2024.